266346-15-0

Basic information

• Product Name: Enrofloxacin Sodium
• Synonyms: Enrofloxacin Sodium;3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-, sodiuM salt (9CI);Enrofloxacin (sodiuM salt);Enoxacin anthracene sodium
• CAS NO: 266346-15-0
• Molecular Formula: C19H21FN3O3.Na
• Molecular Weight: 381.381
• EINECS: 1806241-263-5
• Mol File: 266346-15-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Enrofloxacin Sodium(CAS DataBase Reference)
• NIST Chemistry Reference: Enrofloxacin Sodium(266346-15-0)
• EPA Substance Registry System: Enrofloxacin Sodium(266346-15-0)

Safety Data

• Hazardous Substances Data: 266346-15-0(Hazardous Substances Data)

Usage

General Description

Enrofloxacin Sodium is a synthetic antibacterial drug belonging to the fluoroquinolone group. It is derived from the antibiotic enrofloxacin and is highly effective against a wide range of gram-negative and gram-positive bacteria, as well as some mycoplasma and chlamydia species. Enrofloxacin Sodium works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, preventing the replication and repair of DNA, and ultimately leading to bacterial cell death. This makes it an important tool in the treatment of various bacterial infections in veterinary medicine, including respiratory, urinary tract, skin, and soft tissue infections in cats and dogs. It is available in various formulations for oral and injectable use, and has a good safety profile when used appropriately.